Who is the CEO of Alvotech?

The CEO of Alvotech is Robert Wessman.

What industry does Alvotech belong to?

Alvotech operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Alvotech is headquartered at Saemundargata 15-19, Luxembourg, 102, IS.

Alvotech went public on June 16, 2022.

Alvotech has approximately 1,012 full-time employees.

ALVOW•NASDAQ

Drug Manufacturers - Specialty & Generic

$2.03

$-0.07(-3.33%)

Explore Alvotech’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

CEORobert Wessman

354 422 4500

Saemundargata 15-19, Luxembourg, 102

1,012 Employees

IPO DateJun 16, 2022

CountryIS

Actively Trading

;